Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Ariad Pharmaceuticals, Inc.    ARIA   US04033A1007

 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
04/17/2014 04/21/2014 04/22/2014 04/23/2014 04/24/2014 Date
7.2(c) 7.39(c) 7.79(c) 7.5(c) 7.45(c) Last
9 467 088 5 620 415 10 584 357 7 298 283 6 254 027 Volume
+1.48% +2.64% +5.41% -3.72% -0.67% Change
More quotes
Company
ARIAD Pharmaceuticals, Inc. operates as a biopharmaceutical company, focuses on the discovery, development, and commercialization of small-molecule drugs for the treatment of cancer. The company has four products: Ridaforolimus, Ponatinib, AP1903 and AP26113. Its approach to structure-based drug... 
Surperformance© rating of Ariad Pharmaceuticals, Inc
Trading Rating : Investor Rating :
More about the company
Chart ARIAD PHARMACEUTICALS, INC
Duration : Period :
Ariad Pharmaceuticals, Inc Technical Analysis Chart | ARIA | US04033A1007 | 4-Traders
Full-screen chart
Financials ($)
Sales 2014 88,1 M
EBIT 2014 -204 M
Net income 2014 -208 M
Debt 2014 5,00 M
Yield 2014 -
Sales 2015 159 M
EBIT 2015 -143 M
Net income 2015 -154 M
Finance 2015 56,8 M
Yield 2015 -
PER 2014 -
PER 2015
EV / Sales 2014 14,9x
EV / Sales 2015 7,88x
Capitalization 1 308 M
More Financials
Latest news on ARIAD PHARMACEUTICALS, INC
04/16 ARIAD PHARMACEUTICALS : to Webcast Conference Call on First Quarter 2014 Financi..
04/08 ARIAD PHARMACEUTICALS, INC. : Mallinckrodt to Buy Drugmaker Questcor Pharmaceuti..
04/02 ARIAD PHARMACEUTICALS : ARIA) Pulls Back on Signs its Overbought
04/02 ARIAD PHARMACEUTICALS : Announces Appointment of Hugh Cole, Senior Pharmaceutica..
03/31 ARIAD PHARMACEUTICALS, INC. : Newmont Mining Corp Denies Cutting Output; Indones..
03/26 ARIAD PHARMACEUTICALS : Initiates Pivotal Phase 2 ALTA Trial of AP26113 in Patie..
03/24 ARIAD PHARMACEUTICALS : Other Events, Financial Statements and Exhibits (form 8-..
03/24 ARIAD PHARMACEUTICALS : Announces Initiation of Pivotal Phase 2 ALTA Trial of AP..
03/05 ARIAD PHARMACEUTICALS, INC. : ARIAD Reports 2013 Financial Results and Outlines ..
02/28 ARIAD PHARMACEUTICALS, INC. : ARIAD Releases 4Q and Full Year 2013 Financial Res..
02/25 ARIAD PHARMACEUTICALS, INC. : ARIAD PHARMACEUTICALS INC FILES (8-K) Disclosing T..
02/25 ARIAD PHARMACEUTICALS, INC. : ARIAD Reports 2013 Financial Results and Outlines ..
More news
Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsNeutralBullishNeutral
Technical analysis
Income Statement Evolution
Ariad Pharmaceuticals, Inc : Income Statement Evolution
More Financials
EPS Revisions
Ariad Pharmaceuticals, Inc : EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF